Top Markets
Coin of the day
Ercros, S.A. Ercros, S.A.

Ercros, S.A.

ECR
Rank in Stocks #15008
Ercros, S.A. is a Spanish industrial group primarily engaged in the production... Ercros, S.A. is a Spanish industrial group primarily engaged in the production and distribution of basic chemicals, intermediate chemical products, and pharmaceuticals. The company also extends its market reach through export activities. Its diverse operations are structured into three main divisions: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment manufactures a broad spectrum of products, including ammonia, bioplastics, various caustic solutions (potash and soda), chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. These compounds serve as vital industrial intermediates, essential for applications such as purifying drinking and wastewater, maintaining swimming pools, bleaching paper and textiles, and formulating detergents, solvents, and strippers. They also find use in producing printing inks, animal feed, and cooling equipment. The Intermediate Chemicals division supplies products like formaldehyde, various glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate. These are crucial for manufacturing wood-based panels like chipboards, decorative laminates, and plywoods, as well as resins, paints, and varnishes for the furniture and decoration sectors. Furthermore, they are integral to producing electrical components such as plugs and switches, and contribute to household, sanitary, and packaging materials within the textile tanning industry. Ercros's Pharmacy segment focuses on developing and producing active pharmaceutical ingredients (APIs) and intermediate compounds. Its portfolio includes agents for various therapeutic areas, such as bacterial infections (e.g., azithromycin, clarithromycin, erythromycins, calcium and sodium fosfomycin, fosfomycin trometamol, fusidic acid), high cholesterol (amlodipine besylate), ulcers (famotidine), and fungal infections. With a rich history, Ercros, S.A. was established in 1817 and maintains its corporate headquarters in Barcelona, Spain.
Share Price
$4.15
Market Cap
$379.06M
Change (1 day)
0.14%
Change (1 year)
29.19%
Country
ES
Trade Ercros, S.A. (ECR)
Stock price history for Ercros, S.A. (ECR)
Highest end of day price: $4.15 on 2026-09-01

Lowest end of day price: $5.23 on 2000-01-01
Stock price history of Ercros, S.A. from 2000 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -2.36%
2025 6.25%
2024 32.13%
2023 -20.42%
2022 6.79%
2021 19.44%
2020 2.72%
2019 -29.20%
2018 14.23%
2017 68.98%
2016 175.84%
2015 40.28%
2014 -22.75%
2013 19.84%
2012 -41.63%
2011 2.79%
2010 -55.24%
2009 -9.28%
2008 -58.40%
2007 -50.27%
2006 -2.17%
2005 65.74%
2004 46.99%
2003 24.89%
2002 -0.77%
2001 10.31%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$39.07 26.94%
JP
$7.46 437.45%
TW
$62.66 18.06%
DE
$13.31 -17.10%
SA
$11.26 16.36%
CN